Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.17%
#2 Pons Pons +35.28%
#3 Purr Purr +31.14%
#4 TENDIES TENDIES +31.06%
#5 Starpower Starpower +29.73%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.67%
#7 StonkBroker StonkBroker +26.47%
#8 SkyAI SkyAI +24.19%
#9 Magma Finance Magma Finance +22.28%
#10 PondCoin PondCoin +20.95%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
PT Indofarma Tbk PT Indofarma Tbk

PT Indofarma Tbk

INAF
Clasificación en acciones #29053
PT Indofarma Tbk, along with its affiliated entities, is dedicated to the... PT Indofarma Tbk, along with its affiliated entities, is dedicated to the production and marketing of pharmaceutical goods across Indonesia. The company's activities encompass the commerce and supply of a diverse range of items, including medications, medical equipment, healthcare provisions, various extracts, and herbal products. It also operates its own laboratory facilities and provides specific COVID-19 diagnostic services, such as rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), and Genose tests. Additionally, the firm engages in the export of its merchandise. Established in 1918, Indofarma Tbk maintains its primary operations in Bekasi, Indonesia. Historically, the company was known as PT Indofarma (Persero) Tbk and now functions as a subsidiary of PT. Bio Farma.
Precio por acción
$0.00748841
Última sincronización: 2024-07-01
Capitalización bursátil
$23.21M
Cambio (1 día)
-2.83%
Cambio (1 año)
0.00%
País
ID
Comercio PT Indofarma Tbk (INAF)

Categoría

Healthcare
Ingresos de PT Indofarma Tbk (INAF)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de PT Indofarma Tbk, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de PT Indofarma Tbk desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN